Advertisement

Prevention of Transmission of HIV-1 from Mothers to Infants in Africa

  • Hoosen Coovadia
  • Derseree Archary
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 582)

Keywords

Exclusive Breastfeed Unintended Pregnancy pMTCT Program Infant Dose MTCT Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ayouba, A., Tene, G., Cunin, P., Foupouapouagnigni, Y., Menu, E., Kfutwah, A., Thonnon, J., Scarlatti, G., Monny-Lobe, M., Eteki, N., Kouanfack, C., Tardy, M., Leke, R., Nkam, M., Nlend, A.E., Barre-Sinooussi, F., Martin, P.M., and Nerrient, E.-Yaounde European Network for the Study of In Utero Transmission of HIV-1. (2003). Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaounde, Cameroon. J. Acqui. Immune. Defic. Syndr. 34(3), 274–280.CrossRefGoogle Scholar
  2. Chaix, M.L., Dabis, F., Ekouevi, D., Rouet, F., Tonwe-Gold, B., Viho, I., Bequet, L., Peytavin, G., Toure, H., Menan, H., LeRoy, V., and Rouzioux, C. (2005). Addition of 3 days of ZDV + 3TC postpartum to a short course of ZDV + 3TC and single-dose NVP provides low rate of NVP resistance mutations and high efficacy in preventing peri-partum HIV-1 transmission: The ANRS DITRAME Plus study, Abijan, Cote d’Ivoire. 12th Conference on Retrovirus and Opportunistic Infections, Boston, February 2005 Abstract 72LB.Google Scholar
  3. Chaix, M.L., Montcho, C., Ekouevi, D.K., Rouet, F., Bequet, L., Viho, I., Fassinou, P., Welfens-Ekra, C., LeRoy, V., and Dabis, F. (2004). Genotypic resistance analysis in women who received intrapartum nevirapine associated with short course of zidovudine to prevent perinatal HIV-1 transmission: The DITRAME Plus ANRS 1201/1201 study, Abijan, Cote d’Ivoire. 11th Conference on Retrovirus and Opportunistic Infections, San Francisco, February 2004 Abstract 657.Google Scholar
  4. Chalermchokcharoenkit, A., Asavapiriyanont, S., Teeraratkul, A., Vanprap, N., Chotpitayasunondh, T., Chaowanachan, T., Mock, P., Wilasrusme, S., Skunodom, N., Simonds, R.J., Tappero, J.W., and Culnane, M. (2004). Combination short-course zidovudine plus 2-dose nevirapine for the prevention of mother-to-child transmission: safety, tolerance, transmission, and resistance results. In: Program and abstracts of the 11th Conference of Retrovirus and Opportunistic Infection, San Francisco, February 8–11, 2004 Abstract 96.Google Scholar
  5. Colvin, M., Jackson, D., Levin, J., Chopra, M., Doherty, T., Willumsen, J., and Goga, A. (2005). Risk factors for early transmission of HIV to infants: results from a cohort study across three PMTCT sites in South Africa. 2nd South African AIDS Conference, Durban, 7–10 June 2005 Abstract 462.Google Scholar
  6. Connor, E.M., Sperling, R.S., Gelber, R., Kiselev, P., Scott, G., O’Sullivan, M.J., VanDyke, R., Bey, M., Shearer, W., Jacobson, R.L., Jimenez, E., O’Neill, E., Bazin, B., Delfraissy, J.F., Culnane, M., Coombs, R., Elkins, M., Moye, J., Stratton, P., and Balsley J.-for The Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331, 1173–1180.PubMedCrossRefGoogle Scholar
  7. Cooper, E.R., Charurat, M., Mofenson, L., Hanson, I.C., Pitt, J., Diaz, C., Hayani, K., Handelsman, E., Smeriglio, V., Hoff, R., and Blattner, W.: Women and Infant Transmission Study Group. (2002). Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women prevention of perinatal HIV-1 transmission. J. Acquir. Immune. Defic. Syndr. 29, 484–494.PubMedGoogle Scholar
  8. Coutsoudis, A., Goga, A.E., Rollins, N., and Coovadia, H.M. (2002). Free formula milk for infants of HIV-infected women: blessing or curse. Health Policy Plan 17, 154–160.PubMedCrossRefGoogle Scholar
  9. Coutsoudis, A., Pillay, K., Kuhn, L., Spooner, E., Wei-Yann, T., and Coovadia, H.M. for the South African Vitamin A Study Group. (2001). Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS 15, 379–387.PubMedCrossRefGoogle Scholar
  10. Creese, A., Floyd, K., Alban, A., and Guiness, L. (2002). Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 359, 635–643.CrossRefGoogle Scholar
  11. Cunningham, C.K., Chaix, M.L., and Rekacewicz, C. (2002). Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type-1 transmission: a subtudy of Pediatric Aids Clinical Trials Group 316. J. Infect. Dis. 186, 181–188.PubMedCrossRefGoogle Scholar
  12. Dabis, F. and Ekpini, E.R. (2002). HIV-1/AIDS and maternal and child health in Africa. Lancet 359, 2097–2104.PubMedCrossRefGoogle Scholar
  13. Dabis, F., Bequet, L., Ekouevi, D.C., Viho, I., Rouet, F., Horo, A., Sakarovitch, C., Becquet R., Fassinou, P., Dequae-Merchadou, L., Welffens-Ekra, C., Rouzioux, C., and Leroy, V.: ANRS 1201/1202 DITRAME Plus Study Group. (2005). Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 19, 309–318.PubMedGoogle Scholar
  14. Dabis, F., Msellati, P., Meda, N., Welffens-Ekra, C., You, B., Manigart, O., LeRoy, V., Simonon, A., Cartoux, M., Combe, P., Ouangre, A., Ramon, R., Ky-Zerbo, O., Monthcho, C., Salamon, R., Rouzioux, C., Van de Perre, P., and Mandelbrot, L.: for the Ditrame Study Group. (1999). 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV-1 in breastfed children in Cote d’Ivoire and Burkina Faso: A double blind, placebo controlled multicentre trial. Lancet 353, 786–792.PubMedCrossRefGoogle Scholar
  15. De Cock, K.M., Fowler, M.G., Mercier, E., de Vincenzi, I., Saba, J., Hoff, E., Alnwick, D.J., Rogers, M., and Shaffer, N. (2000). Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 283, 1175–1182.PubMedCrossRefGoogle Scholar
  16. Duerr, A., Hurst, S., Kourtis, A.P., Rutenberg, N., and Jamieson, D.J. (2005). Integrating family planning and prevention of mother-to-child HIV transmission in resource-limited settings. Lancet 366, 261–266.PubMedCrossRefGoogle Scholar
  17. Dorenbaum, A., Cunningham, C.K., Gelber, R.D., Clunane, M., Mofenson, L., Britto, P., Rekacewicz, C., Newell, M.L., Delfraissy, J.F., Cunningham-Schrader, B., Mirochnik, M., and Sullivan, J.L.: International PACTG 316 Team. (2002). Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV-1 transmission: a randomized trial. JAMA 288, 189–198.PubMedCrossRefGoogle Scholar
  18. Eshleman, E., Mracna, M., Guay, L.A., Deseyve, M., Cunningham, S., Mirochnik, M., Musoke, P., Fleming, T., Fowler, M.G., Mofenson, L., Mmiro, F., and Jackson, J.B. (2001). Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET012). AIDS 15, 1951–1957.PubMedCrossRefGoogle Scholar
  19. Eshleman, S.H., Hoover, D.R., Chen, S., Hudelson, S.E., Guay, L.A., Mwatha, A., Fiscus, S.A., Mmiro, F., Musoke, P., Brooks, J.B., Kumwenda, N., and Taha, T. (2005). Nevirapine (NVP) resistance in women ith HIV-1 subtype C, compared with subtypes A and D, after administration of single-dose NVP. J. Infect. Dis. 192, 30–36.PubMedCrossRefGoogle Scholar
  20. Fowler, M.G., Mofenson, L., and McConnell, M. (2003). The interface of perinatal HIV prevention, antiretroviral drug resistance and antiretroviral treatment: What do we really know. J. Acquir. Immune. Defic. Syndr. 34, 308–311.PubMedGoogle Scholar
  21. Guay, L.A., Musoke, P., Fleming, T., Bagenda, D., Allen, M., Nakabiito, C., Sherman, J., Bakaki, P., Ducar, C., Deseyve, M., Emel, L., Mirochnick, M., Fowler, M.G., Mofenson, L., Miotti, P., Dransfield, K., Bray, D., Mmiro, F., and Jackson, J.B. (1999). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET012 randomised trial. Lancet 354, 795–802.PubMedGoogle Scholar
  22. Iliff, P.J., Piwoz, E.G., Tavengwa, N.V., Zunguza, C.D., Marinda, E.T., Nathoo, K.J., Moulton, L.H., and Ward, B.J., the ZVITAMBO study group and Humphrey, J.H. (2005). Early exclusive breast-feeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 19, 699–708.PubMedCrossRefGoogle Scholar
  23. Institute of Medicine of the National Academies. Review of the HIVNET012 perinatal HIV prevention study. April 7 2005. National Academies Press, Washington DC. www.nap.edu.Google Scholar
  24. Jackson, J.B., Musoke, P., Fleming, T., Guay, L.A., Bagenda, D., Allen, M., Nakabiito, C., Sherman, J., Bakaki, P., Maxensia, O., Ducar, C., Deseyve, M., Mwatha, A., Emel, L., Duefield, C., Mirochnik, M., Fowler, M.G., Mofenson, L., Miotti, P., and Gigliotti, M. (2003). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18 month follow-up to the HIVNET012 randomized trial. Lancet 362, 59–68.Google Scholar
  25. Jourdain, G., Ngo-Giang-Huong, N., Le Couer, S., Bowonwatanuwong, G., Kantipong, P., Leechanachai, P., Ariyadej, S., Leenasirimakul, P., Hammer, S., and Lallemant, M. (2004). Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N. Engl. J. Med. 351, 229–240.PubMedCrossRefGoogle Scholar
  26. Kilewo, C. (2002). MITRA Study. 2nd Multifactorial AIDS Conference in Tanzania, 2002 Abstract 061.Google Scholar
  27. Kreitchmann, R., Fuchs, S.C., Suffert, T., and Prussler, G. (2004). Perinatal HIV transmission among low income women participants in the HIV/AIDS control program in Southern Brazil: a cohort study. B. Jog. 111(6), 579–584.Google Scholar
  28. Lallemant, M., Jourdain, G., Le Coeur, S., Mary, J.Y., Ngo-Giang-Huong, N., Keotsawang, S., Kanshana, S., McIntosh, K., and Thaineua, V. (2004). Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N. Engl. J. Med. 351, 217–228.PubMedCrossRefGoogle Scholar
  29. Lallemant, M., Jourdain, G., Le Coeur, S., Kim, S., Keotsawang, S., Comeau, A.M., Phoolcharoen, W., Essex, M., McIntosh, K., and Vithayasai, V. (2000). A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodefi ciency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N. Engl. J. Med. 343, 982–991.PubMedCrossRefGoogle Scholar
  30. Lee, E., Kantor R., Johnston, E., Mateta, P., Zijenah, L., and Katzenstein, D. (2003). Breastmilk shedding of drug resistant subtype C HIV-1 and among women receiving single-dose nevirapine. In: Program and Abstracts of 10th Conference on Retrovirus and Opportunistic Infections, Boston, February 2003 Abstract 96.Google Scholar
  31. Leroy, V., Karon, J.M., Alioum, A., Ekpini, E.R., Meda, N., Greenberg, A.E., Msellati, P., Hudgens, M., Dabis, F., and Wiktor, S.Z. (2002). Twenty-four month effi cacy of maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS 16, 631–641.PubMedCrossRefGoogle Scholar
  32. Leroy, V., Sakarovitch, C., Cortina-Borja, M., McIntyre, J., Coovadia, H., Dabis, F., and Newell, M.L., on behalf of the ghent Group on HIV in Women and Children. (2005). Is there a difference in the effi cacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS 19, 1865–1875.PubMedCrossRefGoogle Scholar
  33. Lyons, F.E., Coughlan, S., Byrne, C.M., Hopkins, S.M., Hall, W.W., and Mulcahy, F.M. (2005). Emergence of antiretroviral resistance in HIV-positive women receiving antiretroviral therapy in pregnancy. AIDS 19, 63–67.PubMedCrossRefGoogle Scholar
  34. McIntyre, J., Martinson, N., Boltz, V., Palmer, S., Coffin, J., Mellors, J., Hopley, M., Kimura, T., Robinson, P., and Mayers, D. (2004). Addition of short course Combivir (CBV) to single dose viramune (sdNVP) for prevention of mother-to-child transmission (MTCT) of HIV-1 can signifi cantly decrease the subsequent development of maternal NNRTI-resistant virus. XV International AIDS Conference, Bangkok, 11–14 July 2004 Abstract LbOrB09.Google Scholar
  35. Moodley, D., Moodley, J., Coovadia, H., Gray, G., McIntyre, J., Hofmeyer, J., Nikodem, X., Hall, D., Gigliotti, M., Robinson, P., Boshoff, L., and Sullivan, J.L. The South African intrapartum nevirapine trial (SAINT). (2003). A multicentre randomized, controlled trial of nevirapine compared to a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodefi ciency virus type-1. J. Infect. Dis. 18, 725–735.CrossRefGoogle Scholar
  36. Morris, L., Martinson, N., Pillay, C., Moodley, D., Chezzi, C., Lupondwana, P., Ntshala, M., Cohen, S., Puren, A., Sullivan, J., Gray, G., and McIntyre, J. (2004). Persistence of nevirapine resistance mutations 6 months following single-dose nevirapine. XV Internation AIDS Conference, Bangkok 11–14 July 2004 Abstract ThOrB1353.Google Scholar
  37. Muro, E., Droste, J., ter Hofstede, H., Bosch, M., Dolmans, W., and Burger, D. (2004). Nevirapine plasma concentrations are still detectable after more than 2 weeks in the majority of women receiving single-dose nevirapine: implications for intervention studies. In Program and Abstracts of 11th Conference on Retrovirus and Opportunistic Infections, San Francisco, February 2004 Abstract 891.Google Scholar
  38. Nduati, R., John, G., Mbori-Ngacha, D., Richardson, B., Overbaugh, J., Mwatha, D., Ndinya-Achola, J., Bwayo, J., Onyango, F.F., Huhes, J., and Kreiss, J. (2000). Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trail. JAMA 283, 1167–1174.PubMedCrossRefGoogle Scholar
  39. Peters, V., Liu, K.L., Dominguez, K., Frederick, T., Melville, S., Hsu, H.W., Ortiz, I., Rakusan, T., Gill, B., and Thomas, P. (2003). Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996–2000, pediatric spectrum of HIV disease cohort. Pediatrics 111, 1186–1191.PubMedCrossRefGoogle Scholar
  40. Petra Study Team. (2002). The efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind placebo-controlled trial. Lancet 359, 1178–1186.CrossRefGoogle Scholar
  41. Quaghebeur, A., Mutunga, L., Mwanyumba, F., Mandaliya, K., Verhofstede, C., and Temmerman, M. (2004). Low efficacy of nevirapine (HIVNET012) in preventing perinatal HIV-1 transmission in a real-life situation. AIDS 18, 1854–1856.PubMedCrossRefGoogle Scholar
  42. Santora, M. New York Times (30 January 2005). US is close to eliminating AIDS in infants, officials say.Google Scholar
  43. Servais, J., Lambert, C., Karita, E., Vanhove, D., Fischer, A., Baurith, T., Schmith, J.T., Schneider, F., Hemmer, R., and Arendt, V. (2004). HIV type-1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda. AIDS Res. Human Retroviruses 20, 279–283.CrossRefGoogle Scholar
  44. Shaffer, N., Chuuachoowong, R., Mock, P.A., Bhadrakom, C., Siriwasin, W., Young, N.L., Chotpitayasunondh, T., Chearskul, S., Roongpisuthipong, A., Chionayon, P., Karon, J., Mastro, T.D., and Simonds, R.J. (1999). Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 353, 773–780.PubMedCrossRefGoogle Scholar
  45. Shapiro, R., Thior, I., Gilbert, P., Lockman, S., Wester, C., Smeaton, L., Stevens, L., Ndung’u, T., Novitsky, V., van Widenfelt, E., Mazonde, P., Lee, T.H., Marlink, R., Lagakos, S., Essex, M., and the Mashi Study Group. (2005). Maternal single-dose nevirapine may not be needed to reduce mother-to-child HIV transmission in the setting of maternal and infant zidocudine and infant single-dose nevirapine: results of a randomized clinical trail in Botswana. In: Program and abstracts of the 12th Conference on Retrovirus and Opportunistic Infections, Boston, February 22–25, 2005 Abstract 74LB.Google Scholar
  46. Sullivan, J.L. (2002). South African intrapartum nevirapine trial: selection of resistance mutations. XIV International AIDS Conference, Barcelona, July 2002 Abstract LbPeB9024.Google Scholar
  47. Sweat, M.D., O’Reilly, K.R., Schmid, G.P., Denison, J., and de Zoysa, I. (2004). Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission to eight African Countries. AIDS 18(12), 1661–1671.PubMedCrossRefGoogle Scholar
  48. Taha, T.E., Kumwenda, N., Gibbons, A., Broadhead, R.L., Fiscus, S., Lema, V., Liomba, G., Nkhoma, C., Miotti, P.G., and Hoover, D.R. (2003). Short post-exposure prophylaxis in newborn infants to reduce mother-to-child transmission of HIV-1: NVAZ randomized clinical trial. Lancet 362, 1171–1177.PubMedCrossRefGoogle Scholar
  49. Temmerman, M., Quaghebeur, A., Mwanyumba, F., and Mandaliya, K. (2003). Mother-to-child transmission in resource poor settings: how to improve coverage. AIDS 17, 1239–1242.PubMedCrossRefGoogle Scholar
  50. The Breastfeeding and HIV Transmission Study Group (The BHITS Group). (2004). Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J. Infect. Dis. 189, 2154–66.CrossRefGoogle Scholar
  51. The Ghent IAS Working Group. (2004). Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials. J. Acquir. Immune. Defic. Syndr. 35(2), 178–186.Google Scholar
  52. UNAIDS and World Health Organization. (2003). AIDS epidemic update, Geneva, UNAIDS. http://www.unaids.org/Unaids/EN/Resources/Publications/corporate+publications/aids+epidemic+update+december+2003.asp)Google Scholar
  53. UNAIDS and World Health Organization. December (2004a). AIDS epidemic update. Geneva, UNAIDS. (http://www.unaids.org/epidemic_update/report_dec01/index.html)Google Scholar
  54. UNAIDS. (2004b). “3 by 5” Progress Report: The way forward: challenges in 2005. WHO Geneva. UNAIDS. 45–47.Google Scholar
  55. UNAIDS, UNICEF and USAID (2004c). Children on the Brink 2004: A joint report of new orphan estimates and a framework for action. 4th edition Page3. www.unaids.org, www.unicef.org and www.usaid.govGoogle Scholar
  56. Vyankandondera, J., Luchters, S., Hassink, E., Pakker, N., Mmiro, F., Okong, P., Kituuka, P., Ndugwa, C., Mukanka, N., Beretta, A., Imperiale, M. Jr, Loeliger, E., Giuiliano, M., and Lange, J. (2003). Reducing the risk of HIV-1 transmission from mother to infant through breasftfeeding using antiretroviral prophylaxis in infants (SIMBA Study). 2nd IAS Conference on Pathogenesis and Treatment, Paris, France 13–16 July 2003 Abstract LB7.Google Scholar
  57. World Health Organization. (2004a). HIV transmission through breastfeeding: Review of available evidence. WHO, Geneva. Page iv.Google Scholar
  58. World Health Organization (2004b). Antiretroviral drugs for treating women and preventing HIV infection in infants: Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. WHO, Geneva. Pages 3–4.Google Scholar
  59. Wiktor, S., Ekpini, E., Karon, J., Nkengasong, J., Maurice, C., Severin, S.T., Roets, T.H., Kouassi, M.K., Lackritz, E.M., Coulibaly, I., and Greenberg, A.E. (1999). Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abijan, Cote d’Ivoire: A randomized trial. Lancet 353, 781–785.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Hoosen Coovadia
    • 1
  • Derseree Archary
    • 2
  1. 1.Centre for HIV and AIDS Networking (HIVAN)University of KwaZulu-Natal Nelson R Mandela School of MedicineCongella DurbanSouth Africa
  2. 2.Department of Paediatrics and Child HealthUniversity of KwaZulu-Natal Nelson R Mandela School of MedicineCongella DurbanSouth Africa

Personalised recommendations